Pharmacotherapies for Treatment of Cocaine Abuse: Preclinical Aspects
- 1 July 1999
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (15) , 2721-2736
- https://doi.org/10.1021/jm9706729
Abstract
No abstract availableThis publication has 94 references indexed in Scilit:
- Immunotherapy for Cocaine AddictionScientific American, 1997
- Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration proceduresNeuropsychopharmacology, 1996
- Ibogaine block of the NMDA receptor: In vitro and in vivo studiesNeuropharmacology, 1996
- Antagonism at delta opioid receptors blocks cocaine's, but not morphine's, enhancement of responding for intracranial stimulation.Experimental and Clinical Psychopharmacology, 1995
- Blockade of cocaine-induced conditioned place preference: Relevance to cocaine abuse therapeuticsLife Sciences, 1995
- Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonistsLife Sciences, 1993
- A novel class of calcium-entry blockers: the 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizinesJournal of Medicinal Chemistry, 1992
- Modulators of N-methyl-D-aspartate protect against diazepam- or phenobarbital-resistant cocaine convulsionsLife Sciences, 1991
- The dopamine hypothesis of the reinforcing properties of cocaineTrends in Neurosciences, 1991
- Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the ratLife Sciences, 1991